Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/3016% below fair value
$5.27−0.07 (-1.31%)
Close on Nov 13, 2026Market cap $342.73MP/E –Yield –
Treace Medical Concepts enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Treace Medical Concepts's enterprise value was $338.73M on Nov 11, 2026, against $185.30M a year earlier. Over the last 5 years it ranged from $93.74M to $1.51B, with a median of $530.51M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $338.73M | +122.9% |
| 2025 | Dec 31, 2025 | $151.97M | -65.0% |
| 2024 | Dec 31, 2024 | $433.76M | -39.4% |
| 2023 | Dec 29, 2023 | $716.26M | -42.2% |
| 2022 | Dec 30, 2022 | $1.24B | +66.6% |
| 2021 | Dec 31, 2021 | $744.19M | – |
See a number that looks wrong?